Taysha Gene Therapies, Inc. (TSHA) Q2 2022 Earnings Call Transcript

Taysha Gene Therapies, Inc. (TSHA) Q2 2022 Earnings Call Transcript

Joining me on today's call are RA Session II Taysha's president, founder, and CEO; Dr. Frederick Porter, chief technical officer; Dr. Suyash Prasad, chief medical officer and head of R&D and Kamran Alam, chief financial officer. After our formal remarks, we will conduct a question-and-answer session and instructions will follow at that time.